Drug
Intravenous insulin
Intravenous insulin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph phase_2
2
40%
Ph phase_4
1
20%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 41 (20.0%)
N/A1 (20.0%)
Trials by Status
not_yet_recruiting120%
terminated120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_2
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
NCT07501533
completedphase_2
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
NCT00812253
completedphase_1
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
NCT00812487
completedphase_4
Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes
NCT01409239
terminatednot_applicable
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
NCT00967642
Clinical Trials (5)
Showing 5 of 5 trials
NCT07501533Phase 2
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
NCT00812253Phase 2
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
NCT00812487Phase 1
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
NCT01409239Phase 4
Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes
NCT00967642Not Applicable
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5